How much is Pulmocide worth in 2026?

Pulmocide has a current valuation of $291.6M based on their Later Stage VC round and secondary market data.

How much funding has Pulmocide raised?

Pulmocide has raised $267.6M in total funding across 0 funding rounds.

Pulmocide

Website

Pulmocide valuation and funding history | Last updated: September 23, 2025

Current Valuation

$291.6M

As of September 23, 2025

Total Funding Raised

$267.6M

Last Round

Later Stage VC

$28.0M

Last Funding

Sep 2025

Funding date

Capital Efficiency

1.09x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Pulmocide is currently valued at $291.6M as of September 23, 2025. The company has raised a total of $267.6M in funding.

Capital Efficiency

With a capital efficiency ratio of 1.09x, Pulmocide has achieved a valuation that is 1.09 times the total capital raised.

Track Pulmocide Valuation Updates

Get notified when Pulmocide raises new funding or valuation changes

Explore More Data

Detailed analysis for Pulmocide

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Pulmocide's valuation history, funding rounds, and growth metrics.

No credit card required

What is Pulmocide Worth in 2026?

Pulmocide is a leading private company in the technology sector. Track Pulmocide's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Pulmocide Valuation is Determined

Private company valuations like Pulmocide's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.